Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres.

MLA

Toellner, Hannah, et al. “Early Clinical Experiences with Nintedanib in Three UK Tertiary Interstitial Lung Disease Centres.” Clinical & Translational Medicine, vol. 6, no. 1, Nov. 2017, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s40169-017-0172-3.

APA

Toellner, H., Hughes, G., Beswick, W., Crooks, M., Donaldson, C., Forrest, I., Hart, S., Leonard, C., Major, M., Simpson, A., & Chaudhuri, N. (2017). Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres. Clinical & Translational Medicine, 6(1), 1–9. https://doi.org/10.1186/s40169-017-0172-3

Chicago

Toellner, Hannah, G. Hughes, W. Beswick, M. Crooks, C. Donaldson, I. Forrest, S. Hart, et al. 2017. “Early Clinical Experiences with Nintedanib in Three UK Tertiary Interstitial Lung Disease Centres.” Clinical & Translational Medicine 6 (1): 1–9. doi:10.1186/s40169-017-0172-3.